
Loading, please wait...

Loading, please wait...

Scientists have significantly advanced extracorporeal life support (ECLS) technology over recent decades. However, engineers still require further research to improve performance-efficiency, hemocompatibility, and long-term stability. Currently, many researchers evaluate early-stage devices under nonstandardized conditions. This makes it difficult to compare or translate data into clinical practice. To address this, an international expert group has established clear recommendations for ECLS device testing according to international norms.
Adopting these standardized protocols will represent a major advancement for the field. These criteria improve methodological consistency and ensure reproducibility across different research groups. Furthermore, the framework fosters a unified approach among clinicians and the medical device industry. By providing clear reporting guidelines, these protocols simplify the review of studies. Consequently, this common framework facilitates faster decision-making in the development and application of ECLS technologies.
Ultimately, these standards will help translate early-stage research into effective clinical tools. This unified methodology ensures that every technological improvement translates directly into better patient outcomes.
Early evaluations are often conducted under nonstandardized conditions, making it difficult to compare data across research groups or translate findings into clinical practice.
The protocols aim to improve methodological consistency, ensure reproducibility, and establish standardized criteria for reporting results in the medical device industry.
By providing a common framework, these standards make the review of studies more straightforward. This reduces the need for additional discussion on testing methods and speeds up decision-making.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. The information provided is based on current research and standardized protocols developed by international experts. Doctors and researchers should consult original source materials and the latest regulatory standards. Refer to the latest local and national guidelines for clinical practice.
References
1. Arens J et al. Standardization of In-Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development. ASAIO J. 2026 Apr 03. doi: 10.1097/MAT.0000000000002623. PMID: 41931830.
2. ELSO (Extracorporeal Life Support Organization). ELSO Guidelines for ECLS / ECMO Training and Centers. Ann Arbor, MI.
3. ISO 5840: Cardiovascular implants — Cardiac valve prostheses — Part 1: General requirements.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


International experts establish standardized in-vitro testing protocols for ECLS devices to improve research consistency, hemocompatibility, and clinical us...
6 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today